(Q38056891)

27 August 2017

title

The role of decitabine for the treatment of acute myeloid leukemia (English)

1 reference

27 August 2017

1 reference

Alex Ganetsky

1

1 reference

27 August 2017

language of work or name

English

0 references

publication date

31 October 2012

1 reference

Annals of Pharmacotherapy

27 August 2017

published in

1 reference

27 August 2017

volume

46

1 reference

27 August 2017

issue

11

1 reference

27 August 2017

page(s)

1511-1517

1 reference

27 August 2017

cites work

Acute myeloid leukaemia

1 reference

Adult acute myeloid leukemia

21 January 2018

1 reference

21 January 2018

1 reference

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial

21 January 2018

1 reference

Cytogenetic abnormalities in adult non-promyelocytic acute myeloid leukemia: a concise review

21 January 2018

1 reference

Anthracycline dose intensification in acute myeloid leukemia

21 January 2018

1 reference

High-dose daunorubicin in older patients with acute myeloid leukemia

21 January 2018

1 reference

Hematopoietic stem-cell transplantation

21 January 2018

1 reference

Salvage therapy for relapsed or refractory acute myeloid leukemia

21 January 2018

1 reference

Epigenetics and human disease: translating basic biology into clinical applications

21 January 2018

1 reference

Cancer epigenetics comes of age

21 January 2018

1 reference

5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy

21 January 2018

1 reference

DNA methyltransferase inhibitors-state of the art.

21 January 2018

1 reference

Aberrant DNA methylation as a cancer-inducing mechanism

21 January 2018

1 reference

Hypermethylation of gene promoters in hematological neoplasia

21 January 2018

1 reference

Gene silencing in cancer in association with promoter hypermethylation

21 January 2018

1 reference

Decitabine--bedside to bench

21 January 2018

1 reference

Multicenter, phase II study of decitabine for the first-line treatment of older patients with acute myeloid leukemia

21 January 2018

1 reference

Statistics in medicine--reporting of subgroup analyses in clinical trials.

21 January 2018

1 reference

Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia

21 January 2018

1 reference

Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells

21 January 2018

1 reference

DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia.

21 January 2018

1 reference

Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine

21 January 2018

1 reference

Feasibility of therapy with hypomethylating agents in patients with renal insufficiency

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1R151

1 reference

27 August 2017

1 reference